Robb Knie - Jan 14, 2025 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)

Role
CEO and President, Director
Signature
/s/ Hayley Springer as Attorney-In-Fact for Robb Knie
Stock symbol
HOTH
Transactions as of
Jan 14, 2025
Transactions value $
$0
Form type
4
Date filed
1/15/2025, 04:15 PM
Previous filing
Aug 21, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOTH Options Award $0 +93K $0.00 93K Jan 14, 2025 Common Stock 93K $1.55 Direct F1
transaction HOTH Options Award $0 +7K $0.00 7K Jan 14, 2025 Common Stock 7K $1.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan, as amended, and vested in full upon grant.
F2 The options were issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.